Oxidative Stress-Mediated Mitochondrial Dysfunction Contributes to Angiotensin II-Induced Nonalcoholic Fatty Liver Disease in Transgenic Ren2 Rats
Open Access
- 30 April 2009
- journal article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 174 (4), 1329-1337
- https://doi.org/10.2353/ajpath.2009.080697
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Angiotensin II-induced non-alcoholic fatty liver disease is mediated by oxidative stress in transgenic TG(mRen2)27(Ren2) ratsJournal of Hepatology, 2008
- Mice lacking angiotensin-converting enzyme have increased energy expenditure, with reduced fat mass and improved glucose clearanceProceedings of the National Academy of Sciences of the United States of America, 2008
- Daily exercise increases hepatic fatty acid oxidation and prevents steatosis in Otsuka Long-Evans Tokushima Fatty ratsAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2008
- Nonalcoholic fatty liver disease and mitochondrial dysfunctionWorld Journal of Gastroenterology, 2008
- Hypertension and fatty liver: guilty by association?Journal of Human Hypertension, 2007
- Irbesartan restores the in-vivo insulin signaling pathway leading to Akt activation in obese Zucker ratsJournal of Hypertension, 2006
- Angiotensin II type 1 receptor blocker ameliorates overproduction and accumulation of triglyceride in the liver of Zucker fatty ratsAmerican Journal of Physiology-Endocrinology and Metabolism, 2004
- Fatty liver, hypertension, and the metabolic syndromeGut, 2004
- Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-γ ligand rosiglitazoneHepatology, 2003
- Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-γ ligand rosiglitazoneHepatology, 2003